British Association of Dermatologists guidelines for the management of people with vitiligo 2021

V Eleftheriadou¹, R Atkar², J Batchelor³, B McDonald⁴, L Novakovic^{5

6}, J V Patel⁷, J Ravenscroft⁸, E Rush^{7

9}, D Shah¹⁰, R Shah^{11

12}, L Shaw¹³, A R Thompson^{12

14}, M Hashme¹⁵, L S Exton¹⁵, M F Mohd Mustapa¹⁵, L Manounah¹⁵; British Association of Dermatologists’ Clinical Standards Unit

Affiliations

¹ Queen Elizabeth Hospital, Mindelsohn Way, Birmingham, B15 2TH, UK.
² Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
³ Centre for Evidence Based Dermatology, University of Nottingham, Nottingham, NG7 2NR, UK.
⁴ The Royal London Hospital, Whitechapel Road, Whitechapel, London, E1 1FR, UK.
⁵ Queen Elizabeth Hospital, Department of Dermatology, Lewisham and Greenwich NHS Trust, London, SE18 4QH, UK.
⁶ St John's Institute of Dermatology, Department of Photodermatology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK.
⁷ Patient representative.
⁸ Queens Medical Centre, Nottingham, NG7 2UH, UK.
⁹ Vitiligo Support UK, London, UK.
¹⁰ Amersham Hospital, Amersham, HP7 0JD, UK.
¹¹ Central & North West London NHS Trust, London, NW1 2PL, UK.
¹² British Psychological Society, Leicester, LE1 7DR, UK.
¹³ Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
¹⁴ South Wales Clinical Psychology Training, Cardiff University, Cardiff, CF10 3AT, UK.
¹⁵ British Association of Dermatologists, Willan House, London, W1T 5HQ, UK.

V Eleftheriadou et al. Br J Dermatol. 2022 Jan.

. 2022 Jan;186(1):18-29.

doi: 10.1111/bjd.20596. Epub 2021 Sep 7.

¹ Queen Elizabeth Hospital, Mindelsohn Way, Birmingham, B15 2TH, UK.
² Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
³ Centre for Evidence Based Dermatology, University of Nottingham, Nottingham, NG7 2NR, UK.
⁴ The Royal London Hospital, Whitechapel Road, Whitechapel, London, E1 1FR, UK.
⁵ Queen Elizabeth Hospital, Department of Dermatology, Lewisham and Greenwich NHS Trust, London, SE18 4QH, UK.
⁶ St John's Institute of Dermatology, Department of Photodermatology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK.
⁷ Patient representative.
⁸ Queens Medical Centre, Nottingham, NG7 2UH, UK.
⁹ Vitiligo Support UK, London, UK.
¹⁰ Amersham Hospital, Amersham, HP7 0JD, UK.
¹¹ Central & North West London NHS Trust, London, NW1 2PL, UK.
¹² British Psychological Society, Leicester, LE1 7DR, UK.
¹³ Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
¹⁴ South Wales Clinical Psychology Training, Cardiff University, Cardiff, CF10 3AT, UK.
¹⁵ British Association of Dermatologists, Willan House, London, W1T 5HQ, UK.

No abstract available

Comment in

British Association of Dermatologist guidelines: a lighthouse to help guide clinicians and researchers planning future clinical trials for vitiligo.
Ezzedine K, Pandya AG. Ezzedine K, et al. Br J Dermatol. 2022 Jan;186(1):3-4. doi: 10.1111/bjd.20815. Epub 2021 Nov 2. Br J Dermatol. 2022. PMID: 34726772 No abstract available.

1. British Association of Dermatologists. Vitiligo. Patient information leaflet. Available at: https://www.skinhealthinfo.org.uk/condition/vitiligo (last accessed 6 July 2021).
1. Mohd Mustapa MF, Exton LS, Bell HK et al. Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016. Br J Dermatol 2017; 176:44-51.
1. Brouwers M, Kho ME, Browman GP et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. CMAJ 2010; 182:E839-42.
1. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.
1. Eleftheriadou V, Thomas K, van Geel N et al. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res 2015; 28:363-9.